Abstract:Objective: Nasopharyngeal carcinoma (NPC) is one of the dominant cancers in South China and Taiwan. Although NPC is highly chemosensitive, the use of chemotherapy for treating patients with recurrent or metastatic NPC has not been very successful. The emergence of drug resistance may be one of the major reasons. However, the mechanisms of drug resistance of NPC have never been addressed before. In this study, we sought to clarify the role of classical drug resistance markers in predicting the chemosensitivity and the prognosis of patients with advanced NPC. Methods: In a cohort of 202 consecutive patients diagnosed at the Department of Pathology of the National Taiwan University Hospital, 44 patients with adequately preserved pretreatment tumor tissues and complete clinical information regarding the details of chemotherapy and tumor response were identified. The expression of multidrug resistance (MDR1), glutathione-S-transferase-pi (GSTpi), and p53 were determined by immunohistochemistry. Tumor response to chemotherapy and survival of the patients were the end-points of this analysis. Results: Thirty-four patients received cisplatin-based regimens, and 28 of them were enrolled in a prospective trial using a doxorubicin-containing regimen. The overall response rate was 70%. Expression of MDR1 was seen in only 5 cases (11%) and was associated with a significantly worse overall survival, yet did not appear to predict chemoresistance to the doxorubicin-containing regimen. Overexpression of p53 was seen in 22 patients, and surprisingly, was correlated with chemoresponse and a trend towards better survival. GSTpi expression was demonstrated in 13 cases (30%) and was not correlated with chemoresistance to cisplatin-containing regimens and overall survival. Conclusion: In this relatively small cohort, positive MDR1 immunostaining predicted a poor overall survival for recurrent or metastatic NPC patients receiving chemotherapy. Overexpression of p53 by immunohistochemical staining, however, was associated with a better response rate to systemic chemotherapy and a trend towards better survival. Copyright (C) 2002 S. Karger AG, Basel.

Expression of Multidrug Resistance-Related Proteins MRP1/LRP/GST-π in Carcinoma of the Gallbladder and Cholangiocarcinoma

Expression of multidrug resistance-related proteins MRP1/MRP2/LRP/Topo II/GST-π in carcinoma of callbladder and cholangiocarcinoma

Expression of multidrug resistance-related proteins MRP1/MRP2/LRP/Topo Ⅱ/GST-π in carcinoma of callbladder and cholangiocarcinoma

Expression of ToPo Ⅱ,MRP,GST-π in Gastric Carcinoma and Its Relationship with Prognosis

Expression And Significance Of Glucose Transporter-1, P-Glycoprotein, Multidrug Resistance-Associated Protein And Glutathione S-Transferase-Pi In Laryngeal Carcinoma

VEGF, Flt-1 and KDR Mrna and Protein Expression in Primary Gallbladder Carcinoma and Their Correlation with Primary Gallbladder Carcinoma Clinicopathological Characteristics

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization

Expression of pGSK-3α/β (Tyr279/216) and XIAP proteins in cholangiocarcinoma and their clinical significance

Expressions and Significances of Topoisomeraseⅱ and Multidrug Resistance-Associated Protein in Human Esophageal Squamous Cell Carcinoma

Study on relationship between mutant p53 and multidrug resistance gene 1 in gastric cancer

The Clinical Value of Apoptosis Protein 2-Mucosa Associated Lymphoid Tissue Lymphoma Translocation Gene 1 Fusion Gene Detection in Tissue of Primary Gastric Lymphoma

Expression of Multi-Drug Resistance-Related Genes MDR3 and MRP As Prognostic Factors in Clinical Liver Cancer Patients.

Significance Of Multidrug Resistance Gene-Related Proteins In The Postoperative Chemotherapy Of Gastric Cancer

Expressions and clinical significance of varied membrae transport proteins in patients with early non-small cell lung cancer

Expression of LRP and Topoll in Gallbladder Carcinoma and Cholangiocarcinoma

Helicobacter Pylori Infection in Cholangiocarcinoma Tissues

Expression of P-gp,MRP,LRP in Nasopharyngeal Carcinoma(NPC) and Clinical Implication

Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy.

Expression and Clinical Significance of Chitinase-3-1ike Protein 1 in Gallbladder Cancer

Expression and clinical significance of GS,E-cadherin and β-catenin in hepatocellular carcinoma

Expression and clinicopathological relationship of survivin ,P53 and PCNA in benign